DelphX Announces Grant of Stock Options

Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved the issuance of 1,100,000 stock options to eligible participants under its stock option plan.

The granted options come with a two-year maturity period and can be exercised at a price of $0.20 per common share.

Toronto, Ontario--(Newsfile Corp. - March 14, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 1,100,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of $0.20 per common share, all in accordance with the Plan.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com

(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244675

FAQ

How many stock options did DelphX (DPXCF) grant in March 2025?

DelphX granted 1,100,000 stock options to eligible participants.

What is the exercise price for DelphX's (DPXCF) March 2025 stock options?

The exercise price is $0.20 per common share.

When do the DelphX (DPXCF) March 2025 stock options expire?

The options have a two-year maturity period from the grant date.

What exchange is DelphX (DPXCF) listed on?

DelphX is listed on TSXV under DELX and OTCQB under DPXCF.